Alternative targets for treating cancer
Alternative targets for treating cancer
批准号:
nhmrc : GNT1057742
负责人:
A/Pr Christopher Burns
金额:
$71.7万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2014
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2014-01-01 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cancer cells are often sustained by evading cell death. Thus, a promising approach to develop new cancer treatments aims to restore their ability to commit cell suicide. Proteins related to Bcl-2 are, in this regard, attractive targets because they are prominent barriers to cell death. This project seeks to uncover how a Bcl-2 relative, Mcl-1, is regulated, and to explore how the mechanisms that underpin these processes can be targeted in cancers (melanomas, leukemias) that it sustains.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding ligand binding within the insulin-like growth factor family with direct application to cancer therapeutic design
-
批准号:nhmrc : 1128553
-
项目类别:Project Grants
-
资助金额:$58.78万
-
财政年份:2017
-
负责人:A/Pr Christopher Burns
-
依托单位:
Understanding ligand binding within the insulin-like growth factor family with direct application to cancer therapeutic design
-
批准号:nhmrc : GNT1128553
-
项目类别:Project Grants
-
资助金额:$86.12万
-
财政年份:2017
-
负责人:A/Pr Christopher Burns
-
依托单位:
Targeting an epigenetic pathway to treat asthma
-
批准号:nhmrc : 1100451
-
项目类别:Project Grants
-
资助金额:$30.42万
-
财政年份:2016
-
负责人:A/Pr Christopher Burns
-
依托单位:
Targeting an epigenetic pathway to treat asthma
-
批准号:nhmrc : GNT1100451
-
项目类别:Project Grants
-
资助金额:$44.41万
-
财政年份:2016
-
负责人:A/Pr Christopher Burns
-
依托单位:
Controlling the pro-survival protein Mcl-1: discovering novel opportunities and developing innovative approaches to target Mcl-1 for treating cancers
-
批准号:nhmrc : 1057742
-
项目类别:Project Grants
-
资助金额:$49.97万
-
财政年份:2014
-
负责人:A/Pr Christopher Burns
-
依托单位:
TBK1 inhibitors as novel therapeutics for rheumatoid arthritis
-
批准号:nhmrc : 1055374
-
项目类别:Development Grants
-
资助金额:$34.12万
-
财政年份:2013
-
负责人:A/Pr Christopher Burns
-
依托单位:
A New Approach for the Treatment of COPD and Lung Cancer using Inhaled Retrometabolic HSP90 Inhibitors
-
批准号:nhmrc : 1038895
-
项目类别:Development Grants
-
资助金额:$42.56万
-
财政年份:2012
-
负责人:A/Pr Christopher Burns
-
依托单位:
国内基金
海外基金
miR-29a "targets" PPAR δ对心力衰竭的作用及作为潜在标志物的研究
-
批准号:81371895
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:臧明玺
-
依托单位: